Laura Rodríguez

429 total citations
27 papers, 186 citations indexed

About

Laura Rodríguez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Laura Rodríguez has authored 27 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Laura Rodríguez's work include Advanced Breast Cancer Therapies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Renal cell carcinoma treatment (3 papers). Laura Rodríguez is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Renal cell carcinoma treatment (3 papers). Laura Rodríguez collaborates with scholars based in Spain, United States and Canada. Laura Rodríguez's co-authors include Sunil V. Patel, Safiya Karim, Kelly Brennan, Sulaiman Nanji, Christopher M. Booth, Thomas Lehrnbecher, Peter Ho, Herbert H. Loong, John Doyle and Deepa S. Subramaniam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Laura Rodríguez

22 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Rodríguez Spain 7 125 57 52 41 24 27 186
Vikas Ostwal India 9 158 1.3× 58 1.0× 20 0.4× 24 0.6× 12 0.5× 63 273
Carlos Bonilla Colombia 7 78 0.6× 48 0.8× 12 0.2× 20 0.5× 18 0.8× 29 158
Yuya Shirai Japan 5 89 0.7× 54 0.9× 17 0.3× 17 0.4× 18 0.8× 14 196
Maruta A. Blatchins United States 6 41 0.3× 42 0.7× 26 0.5× 73 1.8× 12 0.5× 10 228
Yuriko N. Koyanagi Japan 9 88 0.7× 25 0.4× 21 0.4× 42 1.0× 7 0.3× 18 178
Xin Song China 9 54 0.4× 42 0.7× 21 0.4× 30 0.7× 8 0.3× 28 226
Serena Maria Boccia Italy 8 83 0.7× 18 0.3× 25 0.5× 41 1.0× 12 0.5× 25 230
Yuan‐Chin Amy Lee United States 6 70 0.6× 29 0.5× 24 0.5× 58 1.4× 8 0.3× 12 292
Jamal Misleh United States 7 93 0.7× 63 1.1× 38 0.7× 48 1.2× 10 0.4× 24 204
Azra Husić-Selimović Bosnia and Herzegovina 7 63 0.5× 32 0.6× 25 0.5× 36 0.9× 17 0.7× 27 208

Countries citing papers authored by Laura Rodríguez

Since Specialization
Citations

This map shows the geographic impact of Laura Rodríguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Rodríguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Rodríguez more than expected).

Fields of papers citing papers by Laura Rodríguez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Rodríguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Rodríguez. The network helps show where Laura Rodríguez may publish in the future.

Co-authorship network of co-authors of Laura Rodríguez

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Rodríguez. A scholar is included among the top collaborators of Laura Rodríguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Rodríguez. Laura Rodríguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochsenreither, Sebastian, Geòrgia Anguera, Sebastian M. Dieter, et al.. (2025). Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.. Journal of Clinical Oncology. 43(16_suppl). 2639–2639.
2.
Vinceneux, Armelle, Debbie Robbrecht, Karen A. Autio, et al.. (2025). Phase 1 study results of JNJ-78278343 (pasritamig) in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 43(16_suppl). 5017–5017.
3.
Rodríguez, Laura, et al.. (2024). Taxes, Transfers, and Gender: Fiscal Policy Incidence across Fiscal and Care Categories in Jordan. World Bank policy research working paper.
4.
Velasco, Guillermo de, José Luis Perez‐Gracia, Álvaro Pinto, et al.. (2024). Retrospective study assessing the role of the androgen receptor in clear cell renal cell cancer patients treated with VEGFR inhibitors in monotherapy. Clinical & Translational Oncology. 27(5). 2241–2255. 1 indexed citations
5.
Rodríguez, Laura & Matthew Wai‐Poi. (2024). Fiscal Policy, Poverty and Inequality in Jordan: The Role of Taxes and Public Spending. Washington, DC: World Bank eBooks. 1 indexed citations
6.
García-Donás, Jesús, Guillermo de Velasco, Rodrigo Madurga, et al.. (2023). Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study. Clinical & Translational Oncology. 26(3). 732–738. 1 indexed citations
7.
Ahn, M-J., S-W. Kim, Enric Carcereny, et al.. (2022). LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial. Annals of Oncology. 33. S1423–S1423. 15 indexed citations
8.
Albigès, Laurence, Laura Rodríguez, Sang‐We Kim, et al.. (2022). Safety and clinical activity of MEDI5752, a PD-1/CTLA-4 bispecific checkpoint inhibitor, as monotherapy in patients (pts) with advanced renal cell carcinoma (RCC): Preliminary results from an FTIH trial.. Journal of Clinical Oncology. 40(16_suppl). 107–107. 15 indexed citations
9.
Escudero, Adela, et al.. (2022). Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit. International Journal of Clinical Oncology. 27(5). 992–1000. 3 indexed citations
10.
Rodríguez, Laura, et al.. (2022). Rechallenge with immune checkpoint inhibitors beyond severe toxicities, an utopia?. Journal of Clinical Oncology. 40(16_suppl). e14601–e14601. 2 indexed citations
11.
Liu, Xinhua, et al.. (2021). Sunlight exposure in infancy decreases risk of sporadic retinoblastoma, extent of intraocular disease. Cancer Reports. 4(6). e1409–e1409. 7 indexed citations
12.
Assouline, Sarit, Lilian Amrein, Raquel Aloyz, et al.. (2020). IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 61(7). 1653–1659. 6 indexed citations
13.
Jurado‐Román, Alfonso, Guillermo Galeote, Laura Rodríguez, et al.. (2019). TCT-725 Comparative Study of the Hemodynamic Performance of Two Latest Generation Supra-Annular Self-Expanding Transcatheter Aortic Valves (Allegra Versus ACURATE neo). Journal of the American College of Cardiology. 74(13). B711–B711. 1 indexed citations
14.
Rodríguez, Laura, Kelly Brennan, Safiya Karim, et al.. (2018). Disease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based Study. Clinical Colorectal Cancer. 17(4). e651–e661. 58 indexed citations
15.
Angelini, Paola, Laura Rodríguez, Mohammed Zolaly, et al.. (2018). OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE. Mediterranean Journal of Hematology and Infectious Diseases. 10(1). e2018020–e2018020. 4 indexed citations
16.
17.
Rodríguez, Laura & Angela Punnett. (2012). Hodgkin’s Lymphoma in Adolescents and Young Adults. 8(2). 116–116.
18.
Rodríguez, Laura, Marie‐Chantal Ethier, Bob Phillips, et al.. (2012). Utility of peripheral blood cultures in patients with cancer and suspected blood stream infections: a systematic review. Supportive Care in Cancer. 20(12). 3261–3267. 13 indexed citations
19.
Rodríguez, Laura, et al.. (2010). Observaciones sobre la incidencia de leucemias agudas en el Noreste de México. 11(2). 78–81. 3 indexed citations
20.
Sastre, Javier, Ana Custodio, Juan Carlos Sánchez, et al.. (2010). Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer. Anti-Cancer Drugs. 22(2). 185–190. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vikas Ostwal Breakdown of academic impact, for papers by Carlos Bonilla Breakdown of academic impact, for papers by Yuya Shirai Breakdown of academic impact, for papers by Maruta A. Blatchins Breakdown of academic impact, for papers by Yuriko N. Koyanagi Breakdown of academic impact, for papers by Xin Song Breakdown of academic impact, for papers by Serena Maria Boccia Breakdown of academic impact, for papers by Yuan‐Chin Amy Lee Breakdown of academic impact, for papers by Jamal Misleh Breakdown of academic impact, for papers by Azra Husić-Selimović
Rankless by CCL
2026